The increasing pressure on biopharmaceutical quality control (QC) labs to deliver faster, more reliable results is driving demand in rapid and automated technologies. However, transitioning comes with its own set of challenges—from resource limitations and data management complexities to regulatory considerations and integration into existing workflows.
When: Tuesday, June 23, 2026
Time: 4:00 PM Central European Summer Time
Running time: 1 hour
How to join? Go to Merck Webinar
In this webinar, our experts will outline what to consider when evaluating and implementing automated solutions. Through case studies we will demonstrate how present-day QC challenges—such as staffing constraints and increasing production volumes—can be effectively overcome. The webinar will also highlight how to select the right solution and partner, what level of support is required for successful implementation, and why now is the right time to invest in automation.
In this webinar, you will learn about:
- Implementing rapid sterility/bioburden/environmental monitoring methods
- Return on investment (ROI) of rapid methods
- Overcoming regulatory & technology challenges
- The benefits and challenges in day-to-day use
Speakers:
Anne Weeks
Automation & Robotics Specialist, MilliporeSigma (The Life Science business of Merck KGaA, Darmstadt, Germany in the U.S. and Canada)
Johannes Oberdörfer
Senior Manager Field Applications, Rapid Micro Biosystems
Tim Cser
Senior Technology Specialist, Commercial Applications, MilliporeSigma (The Life Science business of Merck KGaA, Darmstadt, Germany in the U.S. and Canada)
Sign up here.
Posted by Dr. Tim Sandle, Pharmaceutical Microbiology Resources (http://www.pharmamicroresources.com/)
No comments:
Post a Comment
Pharmaceutical Microbiology Resources